Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05680155
What this trial is testing

Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Who this might be right for
T2DMType 2 Diabetes Mellitus
Hangzhou Sciwind Biosciences Co., Ltd. 211
Not applicableNot Yet RecruitingNCT07702097
What this trial is testing

Effect of Ajwa Seed Powder on HbA1c and Body Composition in Overweight and Obese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Obesity & OverweightType 2 Diabetes (T2DM)
University of Veterinary and Animal Sciences, Lahore - Pakistan 30
Post-approval studies (Phase 4)Study completedNCT02556918
What this trial is testing

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

Who this might be right for
Hyperglycemia
Emory University 202
Early research (Phase 1)Study completedNCT04990427
What this trial is testing

CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Chronic Kidney Diseases
Lisata Therapeutics, Inc. 6
Post-approval studies (Phase 4)Study completedNCT02981069
What this trial is testing

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Health Science Center at San Antonio 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT07156539
What this trial is testing

HS-20094 in Patients With T2DM

Who this might be right for
Type 2 Diabetes
Jiangsu Hansoh Pharmaceutical Co., Ltd. 546
Post-approval studies (Phase 4)Looking for participantsNCT07019012
What this trial is testing

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Who this might be right for
T2DM
Huazhong University of Science and Technology 170
Not applicableUnknownNCT03564431
What this trial is testing

The Imaging Genetic Study of Type 2 Diabetes and Depression

Who this might be right for
T2DM
Kunming Medical University 120
Large-scale testing (Phase 3)Looking for participantsNCT06716203
What this trial is testing

BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 207
Early research (Phase 1)Study completedNCT07691203
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Cardiovascular Diseases
Humanis Saglık Anonim Sirketi 36
Large-scale testing (Phase 3)Study completedNCT05376969
What this trial is testing

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Daewoong Pharmaceutical Co. LTD. 159
Not applicableStudy completedNCT04653805
What this trial is testing

Therapeutic Approach of Cardiovascular Risk Factors in T2DM by Gender

Who this might be right for
Type 2 DiabetesCardiovascular Risk FactorGender
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 300,000
Post-approval studies (Phase 4)Study completedNCT03050229
What this trial is testing

SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)

Who this might be right for
Nocturnal HypertensionT2DM (Type 2 Diabetes Mellitus)
Jichi Medical University 174
Large-scale testing (Phase 3)WithdrawnNCT00387972
What this trial is testing

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
GlaxoSmithKline
Not applicableStudy completedNCT01991093
What this trial is testing

Multiple Electrode Aggregometry & Clopidogrel Resistance

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Coronary Artery Disease (CAD)Myocardial Infraction
Elpen Pharmaceutical Co. Inc. 280
Not applicableStudy completedNCT03797885
What this trial is testing

People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 730
Testing effectiveness (Phase 2)Ended earlyNCT00806585
What this trial is testing

Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)

Who this might be right for
Type 2 Diabetes MellitusHypertension
Merck Sharp & Dohme LLC 620
Not applicableActive Not RecruitingNCT07464223
What this trial is testing

MRI Assessment of Pancreatic Fat Changes and Islet Function Recovery After Bariatric Surgery in Obese Patients

Who this might be right for
Obesity & OverweightType 2 Diabetes Mellitus (T2DM)Pancreatic Steatosis+1 more
yu li，MD 50
Not applicableActive Not RecruitingNCT06841497
What this trial is testing

Safety and Efficacy Assessment of Unani Formulation 'Dolabi' in Management of Diabetes Mellitus Type II

Who this might be right for
Diabetes MellitusType 2 DM
Hamdard University 100
Large-scale testing (Phase 3)Study completedNCT04039503
What this trial is testing

Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 475
Next Page